The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 12 of the 22 sources its claims cite were checked for support.
Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.
Open accessAbstract
The sympathetic nervous system is an important regulatory mechanism of both metabolic and cardiovascular function, and altered sympathetic activity may play a role in the etiology and/or complications of obesity. In lean subjects, insulin evokes sympathetic activation and vasodilation in skeletal muscle. In obese subjects such vasodilation is impaired and, in turn, may contribute to insulin resistance. To examine the relationship between sympathetic and vasodilatory responses in skeletal muscle to hyperinsulinemia, we simultaneously measured muscle sympathetic nerve activity (MSNA) and calf blood flow at basal and during a 2-h hyperinsulinemic (6 pmol/kg per min) euglycemic clamp in eight lean and eight obese subjects. The major findings of this study are twofold: obese subjects had a 2.2 times higher fasting rate of MSNA, and euglycemic hyperinsulinemia, which more than doubled MSNA and increased calf blood flow by roughly 30% in lean subjects, had only a minor vasodilatory and sympathoexcitatory effect in obese subjects. In contrast, two non-insulin-sympathetic stimuli evoked comparably large increases in MSNA in lean and obese subjects. We conclude that insulin resistance in obese subjects is associated with increased fasting MSNA and a specific impairment of sympathetic neural responsiveness to physiological hyperinsulinemia in skeletal muscle tissue.
Overview
CoChat Summary
TL;DR
In obese humans, fasting muscle sympathetic nerve activity (MSNA) was about 2.2-fold higher than in lean subjects, but hyperinsulinemia failed to normally increase MSNA or calf blood flow. This suggests obesity-related insulin resistance includes a specific impairment of insulin’s sympathoexcitatory and vasodilatory effects in skeletal muscle.
Key findings
- Obese subjects had higher basal MSNA than lean subjects (37±5 vs 17±3 bursts/min), and euglycemic hyperinsulinemia increased MSNA burst frequency by only 9±3% in obese subjects versus 94±10% in lean subjects (P < 0.05 vs lean).
- In lean subjects, the 2-h hyperinsulinemic euglycemic clamp increased calf blood flow by 29±5% and decreased calf vascular resistance by 20±3%; in obese subjects it had no detectable effect on calf blood flow or calf vascular resistance.
- Non-insulin sympathetic stimuli produced comparable MSNA increases in both groups: peak Valsalva responses were 71±8 bursts/min in obese vs 67±4 in lean, and cold pressor responses were 54±6 vs 45±3 bursts/min (P > 0.1).
- Across all 16 subjects, fasting insulinemia correlated directly with fasting MSNA burst frequency (r = 0.56, P < 0.03), and fasting MSNA was inversely related to glucose uptake during the last 30 min of insulin/glucose infusion (r = 0.68, P < 0.004).
Methods
- Eight obese subjects (BMI 33.8±1.6 kg/m², age 38±3 yr) and eight age- and sex-matched lean healthy subjects (BMI 22.2±0.7 kg/m², age 37±3 yr) were studied; all were normotensive, had normal glucose tolerance, took no medication, and had no evidence of metabolic or cardiovascular disease.
- Protocol 1 used a 2-h hyperinsulinemic euglycemic clamp at 1 mU/kg per min (6 pmol/kg per min), with simultaneous MSNA measured by microneurography of the peroneal nerve and calf blood flow measured by venous occlusion plethysmography; non-insulin sympathetic responses were tested with a Valsalva maneuver and cold pressor test.
- Protocol 2 studied five lean subjects with low-dose 2-h hyperinsulinemic euglycemic clamps at 0.5 and 0.15 mU/kg per min; analysis used ANOVA for repeated measures, paired t tests with Bonferroni adjustment, unpaired t tests, and least-squares correlations, with P < 0.05 considered significant.
Limitations
- Stated: the paper says its data “do not elucidate the underlying mechanism of insulin-induced sympathetic activation and vasodilation,” and it offers two possible interpretations for the attenuated sympathetic response in obese subjects—resistance to insulin’s sympathoexcitatory effects versus high basal MSNA already near the maximal insulin-induced response.
- Evident: the main comparison included only eight subjects per group, and the low-dose insulin dose-response studies included only five lean subjects.
- Evident: obese subjects had significantly higher plasma insulin concentrations during the clamp than lean subjects (643±47 vs 449±48 pmol/liter at 120 min), so the groups were not compared at matched insulinemia; the paper also has no formal limitations section.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 2 Not valid · 6 Not checked · 53 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Data in experimental animals regarding effects of insulin resistance and obesity on insulin-induced sympathetic responses are conflicting.”
What the sources say
- Not matchedcites [16] 16. Morgan, D. A., T. W. Balon, and A. L. Mark. 1991. High fructose diet promotes exaggerated sympathetic and pressor responses to hyperinsulinemia in rats. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:A1497. (Abstr.)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Could not verifycites [17] 17. Holt, S., D. A. York, and J. T. R. Fitzsimons. 1983. The effect of corticosterone, cold exposure and overfeeding with sucrose on brown adipose tissue of obese Zucker rats (fa/fa). Biochem. J. 214:215–223. sourceExperimental — accuracy not yet measured
The Discussion reports age-dependent responses to cold and impaired autonomic stimulation of brown-adipose-tissue thermogenesis after sucrose overfeeding in obese rats. It does not address insulin-induced sympathetic responses or say that findings on insulin resistance and obesity are conflicting. Searches for those terms found no decisive passage in our copy; page numbers were unavailable. (LLM, conf=0.73)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In lean subjects, sympathetic activation evoked by acute elevation of plasma insulin to high physiological concentrations does not raise blood pressure (12–14)”
What the sources say
- Partly supportedcites [12] 12. Anderson, E. A., R. P. Hoffman, T. W. Balon, C. A. Sinkey, and A. L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246–2252. sourceExperimental — accuracy not yet measured
The Abstract and Conclusion (pages not provided) report that acute insulin infusion increased sympathetic nerve activity without increasing arterial pressure in normal humans. The Subjects section describes 14 healthy males with BMIs ranging from 21 to 32; it does not establish the result specifically for lean subjects. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [13] 13. Scherrer, U., P. Vollenweider, D. Randin, E. Jéquier, P. Nicod, and L. Tappy. 1993. Suppression of insulin induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation. 88:388–394. source
- Supportedcites [14] 14. Vollenweider, P., L. Tappy, D. Randin, P. Schneiter, E. Jéquier, P. Nicod, and U. Scherrer. 1993. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J. Clin. Invest. 92:147–154. source
The Discussion (p. 6) says that, in lean healthy subjects, acute hyperinsulinemia at high physiological concentrations does not raise arterial pressure. It also describes insulin’s sympathetic activation and vasodilation as opposing effects that may explain this result. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“suggesting that body fat may be an important determinant of resting sympathetic nerve activity in humans (26, 27).”
What the sources say
- Partly supportedcites [26] 26. Spraul, M., E. Ravussin, A. M. Fontvieille, R. Rising, D. E. Larson, and E. A. Anderson. 1993. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J. Clin. Invest. 92:1730–1735. sourceExperimental — accuracy not yet measured
The Abstract and Discussion report that fasting muscle sympathetic nerve activity was positively related to body fat in Caucasian men, but not in Pima Indian men. This supports a possible relationship in one studied group, not the broader suggestion that body fat determines resting sympathetic nerve activity in humans generally; the study also measured an association rather than establishing direction of causation. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not matchedcites [27] 27. Randin, D., P. Vollenweider, L. Tappy, E. Jéquier, P. Nicod, and U. Scherrer. 1993. Sustained sympathetic activation in skeletal muscle in overweight humans. Diabetes. 42:94A. (Abstr.)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In lean healthy subjects, insulin-induced stimulation of muscle blood flow consistently is accompanied by a marked stimulation of sympathetic neural outflow to the same vascular bed (12-14).”
What the sources say
- Partly supportedcites [12] 12. Anderson, E. A., R. P. Hoffman, T. W. Balon, C. A. Sinkey, and A. L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246–2252. sourceExperimental — accuracy not yet measured
The Discussion reports that insulin increased muscle sympathetic nerve activity while causing forearm vasodilation in healthy subjects. But it explicitly says blood flow was measured in the forearm and nerve activity in the leg, so the study does not establish both effects in the same vascular bed. The Subjects section also reports BMI values up to 32, rather than an exclusively lean group. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [13] 13. Scherrer, U., P. Vollenweider, D. Randin, E. Jéquier, P. Nicod, and L. Tappy. 1993. Suppression of insulin induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation. 88:388–394. source
- Supportedcites [14] 14. Vollenweider, P., L. Tappy, D. Randin, P. Schneiter, E. Jéquier, P. Nicod, and U. Scherrer. 1993. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J. Clin. Invest. 92:147–154. source
The Abstract (p. 1) reports that, in six healthy lean subjects, insulin/glucose infusion increased both muscle sympathetic nerve activity and calf blood flow. The Discussion (p. 6) likewise says both increased markedly during infusion, supporting the claimed accompanying responses in skeletal muscle. (LLM, conf=0.91)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“findings in humans, showing that local intraarterial insulin infusion, in contrast to systemic intravenous infusion, did not have any stimulatory effect on sympathetic activity in skeletal muscle (15).”
What the sources say
- Supportedcites [15] 15. Lembo, G., R. Napoli, B. Capaldo, V. Rendina, G. Iaccarino, M. Volpe, B. Trimarco, and L. Saccá. 1992. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J. Clin. Invest. 90:24–29. source
The local-insulinization results report that intraarterial insulin left forearm norepinephrine balance, uptake, and release unchanged in both normotensive and hypertensive subjects. The Discussion contrasts this with an effect on muscle norepinephrine metabolism during systemic insulinization. Page numbers are unavailable in our copy. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
44 more claims · 1 with their cited sources checked
Create a free account to see all 69 claims and every source verdict.
- Probably not a substantial claim. 13
- It may state two separate claims as one. 7
- The quote only partly states this claim. 2
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
Vallbo, A. B., Hagbarth, K. E., Torebjork, H. E., & Wallin, B. G. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.4.919 · Cited by 1,507
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Parati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
General Characteristics of Sympathetic Activity in Human Muscle Nerves
Delius, W., Hagbarth, K. ‐., Hongell, A., & Wallin, B. G. (1972) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1972.tb05157.x · Cited by 831
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman, O. G., Insel, J., Saekow, M., & Olefsky, J. M. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109790 · Cited by 664
Effects of the cold pressor test on muscle sympathetic nerve activity in humans.
Victor, R. G., Leimbach, W. N., Seals, D. R., Wallin, B. G., & Mark, A. L. (1987) · Hypertension · doi:10.1161/01.hyp.9.5.429 · Cited by 519
Cited by
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Nitric oxide release accounts for insulin's vascular effects in humans.
Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L., & Nicod, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117621 · Cited by 756
“sympathetic activation in skeletal muscle tissue (21).”
BackgroundSelf-citationThe Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
“produced striking increases in muscle sympathetic nerve traffic and plasma norepinephrine in healthy lean subjects.(25,78,79)”
BackgroundSympathetic Activity in Obese Subjects With and Without Obstructive Sleep Apnea
Narkiewicz, K., van de Borne, P. J. H., Cooley, R. L., Dyken, M. E., & Somers, V. K. (1998) · Circulation · doi:10.1161/01.cir.98.8.772 · Cited by 523
Metadata
- Authors
- Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Venue
- Journal of Clinical Investigation
- Published
- 1994-06-01
- Volume
- 93
- Issue
- 6
- Pages
- 2365-2371
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC294442
- OpenAlex
- W2063637050
- Cited by
- 285
- References
- 30
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 10 · 2014: 5 · 2013: 3 · 2012: 14
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (36280, 28668)
- Nestec
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- obesity, insulin resistance, muscle sympathetic nerve activity, skeletal muscle vasodilation, hyperinsulinemic-euglycemic clamp, calf blood flow, sympathetic nervous system, insulin signaling
- MeSH terms
- Adult, Blood Glucose, Female, Humans, Insulin, Male, Muscles, Obesity, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Vasodilation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. https://app.cochat.ai/papers/10.1172/jci117242
- The paper
- Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994). Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci117242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.